Comparison between Trident Lifeline IPO and Vital Chemtech IPO.
Trident Lifeline IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Vital Chemtech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Trident Lifeline IPO | Vital Chemtech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Trident Lifeline IPO is up to ₹33.57 Cr whereas the issue size of the Vital Chemtech IPO is up to ₹61.40 Cr. The final issue price of Trident Lifeline IPO is ₹101.00 per share and of Vital Chemtech IPO is ₹101.00 per share.
| Trident Lifeline IPO | Vital Chemtech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹95.00 per share | |
| Issue Price (Upper) | ₹101.00 per share | |
| Issue Price (Final) | ₹101.00 per share | ₹101.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 33,24,000 shares | 60,79,200 shares |
| Fresh Issue Size (Amount) | up to ₹33.57 Cr | up to ₹61.40 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 33,24,000 shares | 60,79,200 shares |
| Issue Size Total (Amount) | up to ₹33.57 Cr | up to ₹61.40 Cr |
Trident Lifeline IPO opens on Sep 26, 2022, while Vital Chemtech IPO opens on Oct 31, 2022. The closing date of Trident Lifeline IPO and Vital Chemtech IPO is Sep 29, 2022, and Nov 03, 2022, respectively.
| Trident Lifeline IPO | Vital Chemtech IPO | |
|---|---|---|
| Anchor Bid Date | Oct 30, 2022 | |
| Issue Open | Sep 26, 2022 | Oct 31, 2022 |
| Issue Close | Sep 29, 2022 | Nov 03, 2022 |
| Basis Of Allotment (Tentative) | Oct 04, 2022 | Nov 09, 2022 |
| Initiation of Refunds (Tentative) | Oct 06, 2022 | Nov 10, 2022 |
| Credit of Share (Tentative) | Oct 07, 2022 | Nov 11, 2022 |
| Listing date (Tentative) | Oct 10, 2022 | Nov 14, 2022 |
| Anchor Lockin End date 1 | Dec 09, 2022 | |
| Anchor Lockin End date 2 | Feb 07, 2023 |
Trident Lifeline IPO P/E ratio is 51.53, as compared to Vital Chemtech IPO P/E ratio of 14.94.
| Trident Lifeline IPO | Vital Chemtech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.57 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 51.53 | 14.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹116.14 Cr. | ₹241.91 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 66.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.61 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.98 | ₹8.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 47.33 | 50.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Trident Lifeline IPO Retail Individual Investors (RII) are offered 16,62,000 shares while in Vital Chemtech IPO retail investors are offered 16,62,000 shares. Qualified Institutional Buyers (QIB) are offered in Trident Lifeline IPO and 12,19,200 shares in Vital Chemtech IPO.
| Trident Lifeline IPO | Vital Chemtech IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,18,000 shares | |
| Market Maker Reservation | 1,75,200 shares | 3,20,400 shares |
| QIB | 12,19,200 shares | |
| NII | 16,62,000 shares | 9,12,000 shares |
| RII | 16,62,000 shares | 21,30,000 shares |
| Employee | ||
| Others | ||
| Total | 33,24,000 shares | 60,79,200 shares |
Trident Lifeline IPO subscribed 1.34x in total, whereas Vital Chemtech IPO subscribed 79.33x.
| Trident Lifeline IPO | Vital Chemtech IPO | |
|---|---|---|
| QIB (times) | 15.48x | |
| NII (times) | 1.69x | 204.05x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.98x | 116.98x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.34x | 79.33x |
